Clinical Trial Update: Using Machine Learning to Identify Responders to TACE or HAIC for uHCC

View source ↗

Summary

A completed clinical trial evaluated machine learning methods to predict responders to transarterial chemoembolization (TACE) or hepatic arterial infusion chemo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Unresectable Hepatocellular Carcinoma (HCC), BCLC Stage B Hepatocellular Carcinoma | Status: COMPLETED